Table 2

Demographic and clinical characteristics according to length of breast feeding*

Characteristic†Never<3 months≥3 and <6 months≥6 monthsp Value for trend
N (%)410 (46)233 (26)124 (14)131 (15)
Female, n (%)262 (64)154 (66)85 (69)90 (69)0.2
Caucasian, n (%)381 (93)208 (89)113 (91)111 (85)0.01
Index of Multiple Deprivation (n=737), n (%)
 Low37 (11)44 (23)26 (27)34 (32)<0.001
 Medium139 (43)93 (48)45 (48)47 (45)
 High149 (46)57 (29)25 (25)24 (23)
Age at symptom onset (years), median (IQR)7.5 (3.4, 11.5)6.0 (2.5, 10.4)5.0 (1.9,. 9.7)4.8 (2, 9.9)0.002
Symptom duration (months), median (IQR)5.6 (2.8, 12.5)5.5 (2.9, 10.3)5.3 (2.9,. 14.3)5.3 (2.9, 14.3)0.5
Active joint count, median (IQR)2 (1, 5)2 (1,. 6)2 (1, 4)2 (1, 6)0.4
Limited joint count, median (IQR)1 (1, 3)1 (1, 3)1 (0, 3)1 (1, 3)0.08
Physician global assessment (n=743), median (IQR)32 (18, 56)30 (18, 57)25 (12, 46)24 (13, 49)0.005
ESR (n=570), median (IQR)18 (6, 47)20 (6, 50)29 (7, 55)21 (9, 53)0.1
CHAQ score (n=674), median (IQR)0.88 (0.25, 1.63)0.63 (0.13, 1.25)0.63 (0.13, 1.25)0.5 (0, 1.13)<0.001
CHAQ >0.75 (n=674), n (%)136 (46)63 (39)35 (41)39 (37)0.001
Parent general evaluation. (100 mm VAS) (n=656), median (IQR)39 (10, 64)16 (3, 45)27 (4, 50)17 (5, 42)0.008
Pain (100 mm VAS) (n=664), median (IQR)29 (7, 54)22 (4, 53)28 (5, 60)20 (6, 45)0.005
JADAS-71, median (IQR)13.2 (7–19.9)10.4 (5.9–16.9)10.2 (5–21.3)10.6 (4.5–15.6)0.1
ILAR Subtype, n (%)
 Systemic arthritis23 (6)8 (4)9 (7)7 (5)0.09
 Oligoarthritis (persistent)189 (46)101 (43)64 (51)59 (45)
 Oligoarthritis (extended)28 (7)13 (6)10 (8)6 (4)
 Polyarthritis (RF negative)79 (19)73 (31)22 (18)38 (29)
 Polyarthritis (RF positive)11 (3)8 (3)5 (4)2 (2)
 Enthesitis-related arthritis32 (8)11 (5)4 (3)4 (3)
 Psoriatic arthritis36 (9)12 (5)8 (7)10 (8)
 Undifferentiated arthritis12 (3)7 (3)2 (2)5 (4)
  • *Duration of breast feeding not reported for 25 children.

  • †Numbers in brackets in first column indicate available data where data items were missing or not available.

  • CHAQ, Childhood Health Assessment Questionnaire; ILAR, International League Against Rheumatism; JADAS, Juvenile Arthritis Disease Activity Scores; RF, rheumatoid factor.